ThyCa Research Grants - Thyroid Cancer Research (Papillary, Follicular, Anaplastic)

ThyCa Research Grants - Thyroid Cancer Research

Funder: ThyCa: Thyroid Cancer Survivors' Association, Inc.

Geographic Scope: International; open to researchers and institutions worldwide

Focus Areas: Research on papillary, follicular, Hurthle cell, variants, and anaplastic thyroid cancer (follicular-cell-derived thyroid cancer)

Program Overview:
ThyCa has supported thyroid cancer research through its Research Fund Campaign since 2003, awarding annual research grants to advance treatment in this underfunded field. The organization has funded grants continuously, with awards ranging from single grants to multiple grants per year.

Key Features

• Funding Structure: 100% of funds donated for research go directly to research; administrative overhead is covered by volunteer efforts
• Selection Process: Proposals are independently reviewed by an expert scientific panel of the American Thyroid Association (ATA)
• Grant Terms: Typically 2-year grants with continuation funding available pending satisfactory progress reports
• Tax Status: ThyCa is a registered 501(c)(3) nonprofit organization

Eligibility

• Open to researchers at any hospital or research institution
• International researchers eligible
• Selection based on scientific merit, researcher qualifications, likelihood of success, and benefit to thyroid cancer patient community

Contact Information

• Phone: 1-877-588-7904
• Email: thyca@thyca.org
• Mailing Address: PO Box 1545, New York, NY 10159-1545
• Website: www.thyca.org

Background

ThyCa established its first research grant in 2003 to Xiulong Xu, Ph.D. at Rush-Presbyterian-St. Luke's Medical Center focusing on BRAF gene mutation in papillary thyroid cancer. The organization has expanded its grant program significantly since then, funding multiple grants annually.